Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi Xue Run Chang Fang is a Traditional Chinese Medicine (TCM) herbal formula developed by the Beijing University of Chinese Medicine Fangshan District Hospital for the treatment of functional constipation. It is specifically indicated for patients presenting with the Qi and blood deficiency syndrome pattern. The formula is designed to replenish Qi, nourish the blood, and moisten the intestines to facilitate bowel movements and improve intestinal motility. Clinical research conducted by the developer has evaluated its efficacy in improving stool consistency, frequency, and associated symptoms such as difficulty in defecation, often comparing it to standard treatments like lactulose. As a hospital-made preparation (院内制剂), it is utilized within the hospital's clinical practice to provide a targeted therapeutic option for chronic constipation patients who do not respond adequately to conventional laxatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qi Xue Run Chang Fang.